Pharmacokinetics and metabolite spectrum of glisoxepide in humans
Speck, U.; Mützel, W.; Kolb, K.H.; Acksteiner, B.; Schulze, P.E.
Arzneimittel-Forschung 24: 404-409
1974
ISSN/ISBN: 0004-4172 PMID: 4408089 Document Number: 81337
Document emailed within 1 workday
Related Documents
Kolb, K.H.; Schulze, P.E.; Speck, U.; Acksteiner, B. 1974: Pharmacokinetics of radioactively labeled glisoxepide in the animal Arzneimittel-Forschung 24: 397-403Demisch, L.; Kaczmarczyk, P.; Seiler, N. 1978: 3,4,5-Trimethoxybenzoic acid, a new mescaline metabolite in humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 6(5): 507-509
Bredberg, U.; Paalzow, L. 1990: Pharmacokinetics of methysergide and its metabolite methylergometrine in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(3): 338-343
Bastrygin, D.V.; Viglinskaia, A.O.; Kolyvanov, G.B.; Litvin, A.A.; Bochkov, P.O.; Mozhaeva, T.I.; Zherdev, V.P. 2011: Pharmacokinetics of afobazole metabolite (M-11) in rats Eksperimental'naia i Klinicheskaia Farmakologiia 74(7): 22-26
Zimmer, A. 1976: Pharmacokinetics and metabolite pattern of clenbuterol in rabbit and dog Arzneimittel-Forschung 26(7a): 1442-1445
Staak, M.; Sticht, G.; Käferstein, H.; Norpoth, T. 1984: Pharmacokinetics and metabolite pattern of tetrazepam and chlordesmethyldiazepam Beitrage Zur Gerichtlichen Medizin 42: 75-79
Kochak, G.M.; Rakhit, A. 1987: Determination of metabolite pharmacokinetics for orally administered prodrugs Drug Metabolism and Disposition: the Biological Fate of Chemicals 15(4): 456-459
Wuis, E.W.; Vree, T.B.; Van Der Kleijn, E. 1990: Pharmacokinetics of intravenously administered dantrolene and its 5-hydroxy metabolite in dogs International Journal of Clinical Pharmacology Research 10(4): 203-210
Hu, L.; Wang, Z.; Xu, R.; Ma, J.; Wang, X.; Zhang, X. 2011: Determination of bupropion and its main metabolite in rat plasma by LC-MS and its application to pharmacokinetics Die Pharmazie 66(12): 924-928
Li, L.; Zhang, Y. 1998: Determination of chlorzoxazone and its metabolite 6-hydroxychlorzoxazone in plasma by HPLC and their pharmacokinetics Yao Xue Xue Bao 33(10): 731-736
Gao, L.-C.; Huang, X.; Tan, Z.-R.; Fan, L.; Zhou, H.-H. 2012: The effects of sodium ferulate on the pharmacokinetics of bupropion and its active metabolite in healthy men European Review for Medical and Pharmacological Sciences 16(9): 1192-1196
Choi, J.S.; Choi, J.S.; Choi, D.H. 2013: Effects of licochalcon a on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats Die Pharmazie 68(11): 882-888
Wang, W.J.; Bai, J.Y.; Zhu, X.Y. 1993: Determination of glyciphosphoramide and its metabolite in plasma and the pharmacokinetics in rats after oral administration Yao Xue Xue Bao 28(10): 738-743
Kim, C-Seong.; Choi, S-Jun.; Park, C-Young.; Li, C.; Choi, J-Shik. 2010: Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats Anticancer Research 30(1): 79-85
Yamaguchi, T.; Hashizume, T.; Matsuda, M.; Sakashita, M.; Fujii, T.; Sekine, Y.; Nakashima, M.; Uematsu, T. 1994: Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects Arzneimittel-Forschung 44(1): 59-64
Paroni, R.; Del Puppo, M.; Borghi, C.; Sirtori, C.R.; Galli Kienle, M. 1989: Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers International Journal of Clinical Pharmacology Therapy and Toxicology 27(6): 302-307
Dingemanse, J.; Bury, M.; Hussain, Y.; van Giersbergen, P. 2000: Comparative tolerability, pharmacodynamics, and pharmacokinetics of a metabolite of a quinolizinone hypnotic and zolpidem in healthy subjects Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(12): 1411-1416
Teunissen, M.W.; De Leede, L.G.; Boeijinga, J.K.; Breimer, D.D. 1985: Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state Journal of Pharmacology and Experimental Therapeutics 233(3): 770-775
Lennernäs, H.; Renberg, L.; Hoffmann, K.J.; Regårdh, C.G. 1993: Presystemic elimination of the beta-blocker pafenolol in the rat after oral and intraperitoneal administration and identification of a main metabolite in both rats and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(3): 435-440
Vree, T.B.; Baars, A.M.; Wijnands, W.J. 1985: High-performance liquid chromatography and preliminary pharmacokinetics of enoxacin and its 4-oxo metabolite in human plasma, urine and saliva Journal of Chromatography 343(2): 449-454